BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 35955886)

  • 1. MicroRNAs in Inflammatory Bowel Disease and Its Complications.
    Krishnachaitanya SS; Liu M; Fujise K; Li Q
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA Molecules-Late Breaking Treatment for Inflammatory Bowel Diseases?
    Aggeletopoulou I; Mouzaki A; Thomopoulos K; Triantos C
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer.
    Masi L; Capobianco I; Magrì C; Marafini I; Petito V; Scaldaferri F
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes.
    Yu YR; Rodriguez JR
    Semin Pediatr Surg; 2017 Dec; 26(6):349-355. PubMed ID: 29126502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease. Part I: Nature and pathogenesis.
    Kirsner JB
    Dis Mon; 1991 Oct; 37(10):605-66. PubMed ID: 1893828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extraintestinal manifestations of inflammatory bowel disease.
    Urlep D; Mamula P; Baldassano R
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):147-63. PubMed ID: 15990704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extraintestinal manifestations in inflammatory bowel disease].
    Vavricka SR
    Ther Umsch; 2023 Dec; 80(9):393-397. PubMed ID: 38095252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal involvement in paediatric inflammatory bowel disease.
    Mutalib M
    Pediatr Nephrol; 2021 Feb; 36(2):279-285. PubMed ID: 31820145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs in inflammatory bowel disease: What do we know and what can we expect?
    de Oliveira ECS; Quaglio AEV; Grillo TG; Di Stasi LC; Sassaki LY
    World J Gastroenterol; 2024 Apr; 30(16):2184-2190. PubMed ID: 38690020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory bowel disease. Part II: Clinical and therapeutic aspects.
    Kirsner JB
    Dis Mon; 1991 Nov; 37(11):669-746. PubMed ID: 1935537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comorbid occurrence of other diagnoses in patients with ulcerative colitis and Crohn's disease.
    Cucino C; Sonnenberg A
    Am J Gastroenterol; 2001 Jul; 96(7):2107-12. PubMed ID: 11467640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentially Expressed miRNAs in Ulcerative Colitis and Crohn's Disease.
    Yarani R; Shojaeian A; Palasca O; Doncheva NT; Jensen LJ; Gorodkin J; Pociot F
    Front Immunol; 2022; 13():865777. PubMed ID: 35734163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Dive Into MicroRNAs in Inflammatory Bowel Disease.
    Alfaifi J; Germain A; Heba AC; Arnone D; Gailly L; Ndiaye NC; Viennois E; Caron B; Peyrin-Biroulet L; Dreumont N
    Inflamm Bowel Dis; 2023 Jun; 29(6):986-999. PubMed ID: 36545755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal Microbiota and miRNA in IBD: A Narrative Review about Discoveries and Perspectives for the Future.
    Oliveira ECS; Quaglio AEV; Magro DO; Di Stasi LC; Sassaki LY
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular manifestations of inflammatory bowel diseases and the underlying pathogenic mechanisms.
    Xiao Y; Powell DW; Liu X; Li Q
    Am J Physiol Regul Integr Comp Physiol; 2023 Aug; 325(2):R193-R211. PubMed ID: 37335014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extraintestinal manifestations in chronic inflammatory bowel diseases].
    Vavricka SR; Greuter T; Zeitz J
    Ther Umsch; 2019 Jan; 75(5):281-285. PubMed ID: 30700241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview.
    Pagani K; Lukac D; Bhukhan A; McGee JS
    Am J Clin Dermatol; 2022 Jul; 23(4):481-497. PubMed ID: 35441942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel disease: beyond the boundaries of the bowel.
    Actis GC; Rosina F; Mackay IR
    Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):401-10. PubMed ID: 21651357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer in Inflammatory Bowel Disease.
    Faye AS; Holmer AK; Axelrad JE
    Gastroenterol Clin North Am; 2022 Sep; 51(3):649-666. PubMed ID: 36153115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.